On Friday, the Dow fell 81.72 points, or 0.4%, to 18132.70. The S&P 500 slipped 6.24 points, or 0.3%, to 2104.50 and the Nasdaq Composite declined 24.36 points, or 0.5%, to 4963.53.

In economic news, the Commerce Department said Friday that U.S. gross domestic product expanded at a 2.2% annual rate in the fourth quarter, down from an initial estimate of 2.6%. Economists surveyed by The Wall Street Journal had predictable an advance of 2%.

Insights about those technology sector stocks that declined during Friday’s trade in U.S. stock exchange, are depicted underneath:

Resonant Inc (NASDAQ:RESN)’s shares plunged -32.77%, and closed at $10.40, during the last trading session, soon after a development-stage company, declared financial results and offered a business update for the fourth quarter and year ended December 31, 2014.

• Raised net proceeds of $16.2 million in an initial public offering
• Made noteworthy progress on the Company’s first product design for a major customer
• Commenced development of a prototype tunable RF filter design
• Expanded the patent portfolio to more than 50 issued and pending patents
• Built out the senior administration team and added technical staff to the R&D team
• Developed new software tools that have improved Resonant’s filter design development capabilities.

Chief Executive Officer, Co-Founder and Chairman Terry Lingren stated: “Last year was transformative for Resonant, as we accomplished a great deal toward the advancement of our technology and business model. In particular, our successful initial public offering offered the resources necessary to grow our uniquely talented development team as well as build out our ISN tool suite and laboratory facilities. These resources will enable us to have multiple projects underway simultaneously, a process we have already begun. We were also able to accelerate our patent filing activity, advance our first project and commence development of a prototype tunable filter design.

Resonant Inc (NASDAQ:RESN), is creating innovative filter designs for radio frequency, or RF, front-ends for the mobile device industry using a fundamentally new technology called Infinite Synthesized Networks®, or ISN®.

Q2 Holdings, Inc. (NYSE:QTWO), declined -5.76%, and closed at $19.81, soon after the news release that a provider of secure, cloud-based virtual banking solutions, declared the upsizing and pricing of its follow-on public offering. The size of the offering has been raised from the formerly declared 4,559,156 shares to 5,122,353 shares at a price to the public of $19.75 per share. Q2 is selling 1,500,000 shares of ordinary stock and certain existing stockholders of Q2 are selling 3,622,353 shares of ordinary stock. In addition, the underwriters of the offering have been granted a 30-day option to purchase from Q2 and the selling stockholders up to an additional 768,352 shares of ordinary stock, on the same terms and conditions. Q2 will not receive any proceeds from the sale of the shares by the selling stockholders.

J.P. Morgan, Morgan Stanley and Stifel are serving as joint book-running managers for the offering with Raymond James, Canaccord Genuity and Needham & Company acting as co-managers.

Q2 is a leading provider of secure, cloud-based virtual banking solutions headquartered in Austin, Texas. Q2 enables regional and community financial institutions, or RCFIs, to deliver a robust suite of integrated virtual banking services and engage more effectively with their retail and commercial account holders who expect to bank anytime, anywhere and on any device.

Allscripts Healthcare Solutions Inc (NASDAQ:MDRX), dipped -5.84%, and closed at $12.01, after the news release that Allscripts (MDRX) declared that certain members of its administration team will be attending the following forthcoming investor events:

• The 2015 Cowen and Company Health Care Conference, to be held March 2-4, 2015 at The Boston Marriott Copley Place in Boston, Mass.
• The SunTrust Robinson Humphrey Healthcare IT Summit Conference to be held March 5-6, 2015 at The Grand Summit Hotel at Canyons Resort in Park City, Utah
• The Barclays Global Healthcare Conference, to be held March 10-12, 2015 at The Loews Miami Beach Hotel in Miami, Fla.

Allscripts administration also plans to host the Sixth Annual Financial Community Town Hall at the HIMSS Annual Conference & Exhibition, to be held April 13, 2015 at 6:00 pm (CT) through 7:30 pm at McCormick Place in Chicago, Ill.

Allscripts Healthcare Solutions Inc (NASDAQ:MDRX), is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health(TM).

Universal Display Corp. (NASDAQ:OLED), dropped -6.45%, and closed at $34.39, soon after the news release that Universal Display Corporation (OLED), enabling energy-efficient displays and lighting with its UniversalPHOLED® technology and materials, declared its results for the fourth quarter and year ended December 31, 2014. For the full year 2014, the Company stated proceeds of $191.0 million, up 30% contrast to proceeds of $146.6 million for 2013. Operating revenue raised to $58.6 million for the year, up 53% from $38.2 million for 2013. The Company stated net revenue of $41.9 million, or $0.90 per diluted share, for the full year 2014, contrast to net revenue of $74.1 million, or $1.59 per diluted share, for 2013. (The 2013 net revenue comprised of a total deferred revenue tax benefit of $41.4 million. Not including this item, 2013 adjusted net revenue was $32.6 million, or $0.70 per diluted share.

Fourth Quarter Results:

Proceeds for the fourth quarter of 2014 were $56.2 million contrast to proceeds of $49.5 million for the same quarter of 2013. Growth in fourth quarter proceeds was led by a 10% raise in material sales, which rose to $28.1 million, up from $25.5 million in the fourth quarter of 2013, reflecting strong volume growth in green and red emitter material sales. Royalty and license fees were $28.0 million in the fourth quarter of 2014 contrast to $23.1 million in the same quarter of 2013. The Company recognized $25 million in SDC licensing proceed in the fourth quarter of 2014, up from $20 million in the same quarter of 2013.

Operating expenses for the fourth quarter of 2014 were $39.1 million contrast to $30.1 million in the same quarter of 2013. Cost of materials for the fourth quarter of 2014 was $12.1 million contrast to $7.7 million in the fourth quarter of 2013, reflecting an raise in the quantity of material shipped, changes in product mix and an inventory write-down of $3.9 million.

Universal Display Corp. (NASDAQ:OLED), is a leader in developing and delivering state-of-the-art, organic light emitting diode (OLED) technologies, materials and services to the display and lighting industries. Founded in 1994, the Company presently owns or has exclusive, co-exclusive or sole license rights with respect to more than 3,500 issued and pending patents worldwide.